News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Summit Global Investments has acquired 19,035 shares of The Andersons, Inc. (NASDAQ:ANDE), valued at approximately $1.3 million, increasing institutional ownership to 87.06%. The company received a consensus "Buy" rating from analysts with an average price target of $95.00, following better-than-expected Q2 earnings of $2.15 …
Renaissance Technologies LLC has acquired a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM), purchasing 58,227 shares valued at approximately $1.12 million. Other institutional investors like Vanguard Group and Jennison Associates also increased their holdings. Tandem Diabetes Care reported mixed quarterly results with revenue …
Candel Therapeutics (NASDAQ:CADL) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $19.29, significantly above its current trading price of $11.72. Despite recent insider share sales and a larger-than-expected quarterly loss of $0.52 per share, analysts maintain …
Banco Santander is planning concurrent exchange offers in Brazil and the U.S. to acquire all outstanding common shares, preferred shares, units, and ADSs of Banco Santander (Brasil) S.A. not currently owned by Santander. The offer includes a 23.6% premium to Santander Brasil's unaffected unit …
Banco Santander is proposing concurrent exchange offers in Brazil and the U.S. to acquire all outstanding shares, units, and ADSs of Santander Brasil not currently owned by Banco Santander. The offer implies a 23.6% premium over Santander Brasil's unaffected unit price, valuing units at …
Andersen Group Inc. (NYSE: ANDG) reported better-than-expected sales for the second quarter, with revenue growing 23.7% and adjusted earnings of $2.94 per share. Despite a 10% dip in pre-market trading, analysts from Baird and Truist Securities raised their price targets on the stock, maintaining …
Candel Therapeutics (NASDAQ:CADL) stock fell 4.6% after reporting a quarterly loss of $0.52 per share, missing the consensus estimate of $0.27. Despite the earnings miss, management highlighted progress towards a biologics license application submission in Q4 and a first commercial product target for 2027. …
Candel Therapeutics, Inc. (CADL) has seen its average 12-month price target raised to $20.88 by analysts, up from $20.5, with individual forecasts ranging from $12 to $29. This new target suggests a potential upside of approximately 77% from its closing price on August 13. …
BofA has increased its price target for Candel Therapeutics (CADL) to $12, up from the previous $9. This adjustment follows several recent announcements from Candel Therapeutics, including its Q2 earnings results, the initiation of a global Phase 3 trial for a lung-cancer drug, and …
Standex International (SXI) reported strong fiscal 2026 results, with revenue reaching $891.6M and diluted EPS of $8.67, significantly up from the prior year. This growth was fueled by both strategic acquisitions and organic expansion, leading to a more than doubling of net income to …
Fitch Ratings has affirmed Banco Santander Argentina S.A.'s Long-Term Foreign Currency IDR at 'B-?' and Local Currency IDR at 'B', with a Stable Outlook. The ratings are supported by the bank's strong domestic franchise, good financial profile, and manageable sovereign exposure, despite pressures from …
Standex International Corporation (NYSE:SXI) has received a "Moderate Buy" consensus rating from analysts, with four out of five recommending a buy and one a hold. The average 12-month price target is set at $298.67. The company recently reported strong quarterly earnings, beating estimates with …
Banco Santander S.A. significantly reduced its stake in Carnival Corporation by 80.9% in the second quarter, now holding 9,547 shares valued at $273,000. Despite this reduction, institutional investors collectively own 67.19% of Carnival, and analysts maintain a "Moderate Buy" consensus rating with an average …
An insider at Banco Santander (Brasil) SA (BSBR), Nicolas Vergara, sold 17,800 shares for approximately $102,172. This transaction is the only sale by Vergara in the past year, and while overall insider activity shows more selling than buying, the stock is considered modestly undervalued …
* Candel Therapeutics press release [https://seekingalpha.com/pr/20618191-candel-therapeutics-reports-second-quarter-2026-financial-results-and-recent-corporate] (CADL [https://seekingalpha.com/symbol/CADL]): Q2 GAAP EPS of -$0.52 misses by $0.29. * Cash and cash equivalents of $201.6 million, as of June 30, 2026, are expected to be sufficient to fund the Company’s current operating plan into Q1 2028, …
Candel Therapeutics (NASDAQ:CADL) recently reached a new 52-week high of $11.45, closing at approximately $11.18 on significant trading volume. Despite missing quarterly EPS expectations by $0.30 with a loss of $0.52 per share, analyst sentiment remains generally positive, holding a "Moderate Buy" consensus and …
Royal Bank of Canada has lowered its price target for Kayne Anderson BDC (NYSE:KBDC) to $15.00 from $16.00, while maintaining an "outperform" rating. This new target suggests a potential upside of 10.70% from the stock's current price. The company recently reported strong quarterly earnings, …
This article provides an overview of analyst insights, price targets, and recommendations for Andersons Inc (AKG.MU). It lists several analyst actions, including upgrades and reiterations of ratings from firms like BMO Capital and Benchmark, dating from December 2025 to August 2026. The current stock …
Candel Therapeutics (CADL) reported a Q2 net loss of $0.52 per share, which is significantly wider than the FactSet estimate of a $0.21 loss per share. The article provides this key financial update along with recent news and company profile information.
Search by ticker symbol or company name and select a result to open its chart.